These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 2678074)
61. Clinical Pharmacology of Bronchodilator Medications. Williams DM; Rubin BK Respir Care; 2018 Jun; 63(6):641-654. PubMed ID: 29794201 [TBL] [Abstract][Full Text] [Related]
62. [Effects of the new brondilatator reproterol on the cardiac function during treatment of bronchial asthma and chronic obstructive bronchitis (author's transl)]. Zecevic D; Tabori D; Mijatovic S; Todic V; Concic B; Aurich R; Stadler R Arzneimittelforschung; 1977; 27(12):53-5. PubMed ID: 576832 [TBL] [Abstract][Full Text] [Related]
63. [Obstructive air way disease in infants and children]. Frey U; Barben J; Hammer J Ther Umsch; 2013 Nov; 70(11):669-79. PubMed ID: 24168801 [TBL] [Abstract][Full Text] [Related]
64. Measures of reversibility in response to bronchodilators in chronic airflow obstruction. Packe GE Thorax; 1991 Jul; 46(7):544. PubMed ID: 1877046 [No Abstract] [Full Text] [Related]
65. Comparative assessment of the efficiency of three new bronchodilators (salbutamol, terbutaline, Th 1165 a) in the management of patients with chronic obstructive lung disease. Manicatide MA; Racoveanu CL; Nicolaescu VV; Teculescu DB Rev Roum Med Intern; 1973; 10(1):49-56. PubMed ID: 4571833 [No Abstract] [Full Text] [Related]
66. [Development of theophylline in treatment of asthma and chronic obstructive pulmonary disease]. Xu YJ Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Jun; 26(3):319-22. PubMed ID: 15266839 [TBL] [Abstract][Full Text] [Related]
67. Are anticholinergics first choice bronchodilators in the treatment of stable chronic obstructive pulmonary disease? Nava S Monaldi Arch Chest Dis; 2000 Apr; 55(2):168-9. PubMed ID: 10949881 [No Abstract] [Full Text] [Related]
68. [Beta2 agonists and anticholinergics. Inhalation therapy in acute deterioriation of asthma and chronic obstructive pulmonary disease]. Ringbaek TJ; Phanareth K; Lange P Ugeskr Laeger; 1996 Oct; 158(42):5957-62. PubMed ID: 8928288 [No Abstract] [Full Text] [Related]
73. [Body plethysmographic investigations with the new bronchodilator NAB365 (author's transl)]. Kaik G MMW Munch Med Wochenschr; 1975 May; 117(22):959-60. PubMed ID: 807812 [TBL] [Abstract][Full Text] [Related]
74. [Beta-2-agonists are still of value. Tolerance does not affect the bronchodilating effect]. Larsson K Lakartidningen; 1997 Oct; 94(42):3741-2, 3745-6, 3749-50. PubMed ID: 9411129 [TBL] [Abstract][Full Text] [Related]
76. [Eight parameters of ventilatory function in evaluating the therapeutic effects of bronchodilators]. Huang ZB Zhonghua Yi Xue Za Zhi; 1984 Jan; 64(1):29-32. PubMed ID: 6430490 [No Abstract] [Full Text] [Related]
77. Therapeutic implications of a precise diagnosis of airflow obstruction. Picado C Eur Respir J; 1990 Oct; 3(9):1091-4. PubMed ID: 1981193 [No Abstract] [Full Text] [Related]
78. The patient with asthma: implications for dental practice. Guggenheimer J; Moore PA Compend Contin Educ Dent; 2009 May; 30(4):200-2, 205-7; quiz 208, 210. PubMed ID: 19441736 [TBL] [Abstract][Full Text] [Related]
79. The role of bronchodilators in bronchospastic disease. A clinical and laboratory study. Holloway R; Valjee KD; Singh RN Respiration; 1972; 29(5):522-31. PubMed ID: 4569022 [No Abstract] [Full Text] [Related]
80. Controversies in pulmonary medicine. Patients with COPD should be started initially on anticholinergic bronchodilators. Chapman KR; Wanner A Am Rev Respir Dis; 1988 Oct; 138(4):1074-5. PubMed ID: 2904777 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]